Percentage of chronic lymphocytic leukemia cells expressing B7.1 and CD40L after transduction with helper virus–containing and helper virus–free amplicon stocks
| Treatment . | CD40L (%) . | B7.1 (%) . | CD40L and B7.1 (%) . |
|---|---|---|---|
| HSVlac | 2.0 | 12.5 | 0.5 |
| hf-HSVlac | 1.4 | 16.3 | 0.3 |
| HSVCD40L | 77.4 | 13.1 | 7 |
| hf-HSVCD40L | 48.6 | 41.6 | 14.7 |
| Treatment . | CD40L (%) . | B7.1 (%) . | CD40L and B7.1 (%) . |
|---|---|---|---|
| HSVlac | 2.0 | 12.5 | 0.5 |
| hf-HSVlac | 1.4 | 16.3 | 0.3 |
| HSVCD40L | 77.4 | 13.1 | 7 |
| hf-HSVCD40L | 48.6 | 41.6 | 14.7 |